Familial tumoral calcinosis: A forty-year follow-up on one family

Journal of Bone and Joint Surgery

Volumn 91, Issue 3, 2009, Pages 664-671

  Carmichael, Kelly D ^a   Bynum, James A ^a   Evans, E Burke ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62549136150     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.G.01512     Document Type: Article

References (35)

1. Pakasa NM, Kalengayi RM. Tumoral calcinosis: a clinicopathological study of 111 cases with emphasis on the earliest changes. Histopathology. 1997;31:18-24.
2. Tezelman S, Siperstein AE, Duh QY, Clark OH. Tumoral calcinosis. Controversies in the etiology and alternatives in the treatment. Arch Surg. 1993;128:737-45.
3. Viegas SF, Evans EB, Calhoun J, Goodwiller SE. Tumoral calcinosis: a case report and review of the literature. J Hand Surg [Am]. 1985;10:744-8.
4. Slavin RE, Wen J, Kumar D, Evans EB. Familial tumoral calcinosis: a clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis. Am J Surg Pathol. 1993;17:788-802.
5. Knowles SA, Declerck G, Anthony PP. Tumoral calcinosis. Br J Surg. 1983;70:105-7.
6. Martinez S. Tumoral calcinosis: 12 years later. Semin Musculoskelet Radiol. 2002;6:331-9.
7. Baldursson H, Evans EB, Dodge WF, Jackson WT. Tumoral calcinosis with hyperphosphatemia. A report of a family with incidence in four siblings. J Bone Joint Surg Am. 1969;51:913-25.
8. Benet-Pagès A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet. 2005;14:385-90.
9. Ichikawa S, Lyles KW, Econs MJ. A novel GALNT3 mutation in a pseudoauto-somal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab. 2005;90:2420-3.
10. Wilson MP, Lindsley CB, Warady BA, Johnson JA. Hyperphosphatemia associated with cortical hyperostosis and tumoral calcinosis. J Pediatr. 1989;114:1010-3.
11. Savaci N, Avunduk MC, Tosun Z, Hosnuter M. Hyperphosphatemic tumoral calcinosis. Plast Reconstr Surg. 2000;105:162-5.
12. Prince MJ, Schaeffer PC, Goldsmith RS, Chausmer AB. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25- dihydroxycholecalciferol concentrations. Ann Intern Med. 1982;96:586-91.
13. Topaz O, Indelman M, Chefetz I, Geiger D, Metzker A, Altschuler Y, Choder M, Bercovich D, Uitto J, Bergman R, Richard G, Sprecher E. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet. 2006;79:759-64.
14. Polykandriotis EP, Beutel FK, Horch RE, Grunert J. A case of familial tumoral calcinosis in a neonate and review of the literature. Arch Orthop Trauma Surg. 2004;124:563-7.
15. Seifort G. Heterotope (extrossare) Verkalkung (Kalzinose). Atiologie, Pathogenese, und klinische Bedeutung. Pathologe. 1997;18:430-8.
16. Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita T, Silver J, Igarashi T, Fujita T. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab. 2005;90:5523-7.
17. Topaz O, Bergman R, Mandel U, Maor G, Goldberg R, Richard G, Sprecher E. Absence of intraepidermal glycosyltransferase ppGalNac-T3 expression in familial tumoral calcinosis. Am J Dermatopathol. 2005;27:211-5.
18. Lyles KW, Burkes EJ, Ellis GJ, Lucas KJ, Dolan EA, Drezner MK. Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity. J Clin Endocrinol Metab. 1985;60:1093-6.
19. Larsson T, Davis SI, Garringer HJ, Mooney SD, Draman MS, Cullen MJ, White KE. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology. 2005;146:3883-91.
20. Larsson T, Yu X, Davis SI, Draman MS, Mooney SD, Cullen MJ, White KE. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab. 2005;90:2424-7.
21. Frishberg Y, Topaz O, Bergman R, Behar D, Fisher D, Gordon D, Richard G, Sprecher E. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med. 2005;83:33-8. Erratum in: J Mol Med. 2005;83:240.
22. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet. 2004;36:579-81.
23. Calloway DM, Saldana MJ. Combined modality treatment for tumoral calcinosis. Orthop Rev. 1993;22:365-9.
24. McKee PH, Liomba NG, Hutt MS. Tumoral calcinosis: a pathological study of fifty-six cases. Br J Dermatol. 1982;107:669-74.
25. Hammoud S, McCarthy EF, Weber K. Tumoral calcinosis in infants: a report of three cases and review of the literature. Clin Orthop Relat Res. 2005;436:261-4.
26. Bhagia UT, Bertrand SL, Iwinski HJ. Tumoral calcinosis in an infant. J South Orthop Assoc. 1997;6:101-5.
27. Kisembo H, Kiguli-Malwadde E, Kawooya MG. Tumoral calcinosis: report of nine cases. East Afr Med J. 2000;77:574-5.
28. Buschmann WR, Myers W, Sager G. Tumoral calcinosis. Case presentation and review. Orthop Rev. 1989;18:440-2.
29. Majeed SA. Chronic recurrent multifocal osteomyelitis associated with tumoral calcinosis. J Bone Joint Surg Br. 1994;76:325-7.
30. Thakur A, Hines OJ, Thakur V, Gordon HE. Tumoral calcinosis regression after subtotal parathyroidectomy: A case presentation and review of the literature. Surgery. 1999;126:95-8.
31. Mockel G, Buttgereit F, Labs K, Perka C. Tumoral calcinosis revisited: pathophysiology and treatment. Rheumatol Int. 2005;25:55-9.
32. Giardina F, Sundanese A, Bertoni F, Guerra E, Paderni S. Tumoral calcinosis of the popliteal space. Orthopedics. 2004;27:1104-7.
33. Adams WM, Laitt RD, Davies M, O'Donovan DG. Familial tumoral calcinosis: association with cerebral and peripheral aneurysm formation. Neuroradiology. 1999;41:351-5.
34. Gregosiewicz A, Warda E. Tumoral calcinosis: successful medical treatment. A case report. J Bone Joint Surg Am. 1989;71:1244-9.
35. Seimon LP. Tumoral calcinosis: a surgical problem. J Pediatr Orthop. 1982;2:409-15.